|
Market Closed -
BME
11:35:28 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 60.00 EUR | -0.99% |
|
-0.83% | -5.51% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 21.68x | 4.16x | 13.16x | 4x | 15.71x | 18.85x | 1.59% | 3.6B | ||
| 32.93x | 20.89x | 0.62x | 11.96x | 24.23x | 25.69x | 0.6% | 1,031B | ||
| 29.57x | - | -1.6x | - | - | - | 2.02% | 641B | ||
| 32.73x | -359.18x | 0.14x | 7.6x | 15.79x | 16.42x | 2.67% | 453B | ||
| 19.66x | 7.06x | 1.65x | 4.67x | 11.58x | 12.84x | 2.83% | 349B | ||
| 21.66x | 6.1x | -9.1x | 5.59x | 13.87x | 14.79x | 2.87% | 290B | ||
| 20.88x | 4.67x | 1.11x | 4.29x | 12.24x | 12.88x | 2.06% | 252B | ||
| 27.19x | 20.54x | 2.45x | 7.03x | 12.5x | 16.15x | 2.35% | 232B | ||
| 13.11x | 5.52x | -4.16x | 4.72x | 9.86x | 11.42x | 3.87% | 201B | ||
| -44.72x | 9.96x | 0.3x | 6.46x | 25.22x | 61.43x | 2.25% | 181B | ||
| 17.83x | 1.85x | 1.03x | 3.37x | 8.6x | 9.81x | 6.05% | 162B | ||
| 32.11x | 6.14x | 3x | 9.27x | 20.96x | 21.86x | -.--% | 138B | ||
| 11.9x | 5.61x | 0.19x | 3.31x | 8.6x | 9.32x | 3.78% | 136B | ||
| 12.25x | 1.24x | -6.15x | 2.17x | 7.03x | 7.83x | 5.54% | 107B | ||
| 14.01x | 4.53x | -2.24x | 2.77x | 8.21x | 9.14x | 3.75% | 101B | ||
| 22.45x | 5.06x | 1.34x | 7.54x | 14.3x | 15.01x | 1.97% | 71.2B | ||
| 45.98x | 1.23x | 16.61x | 2.79x | 9.85x | 29.23x | 3.54% | 57.62B | ||
| 21.87x | 1.71x | -0.14x | 1.71x | 8.06x | 13.85x | 0.32% | 55.96B | ||
| 32.85x | 4.49x | 1.74x | 7.76x | 26.34x | 27.22x | 0.55% | 45.1B | ||
| 19.15x | 1.92x | 4.89x | 3.45x | 12.87x | 14.34x | 2.19% | 43.95B | ||
| Average | 20.25x | -12.97x | 1.24x | 5.29x | 13.99x | 18.32x | 2.54% | 227.57B | |
| Weighted average by Cap. | 23.40x | -31.91x | -0.26x | 7.15x | 16.27x | 19.49x | 2.23% |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















